Correlation Between Salesforce and Humacyte
Can any of the company-specific risk be diversified away by investing in both Salesforce and Humacyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Humacyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and Humacyte, you can compare the effects of market volatilities on Salesforce and Humacyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Humacyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Humacyte.
Diversification Opportunities for Salesforce and Humacyte
-0.07 | Correlation Coefficient |
Good diversification
The 3 months correlation between Salesforce and Humacyte is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Humacyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Humacyte and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Humacyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Humacyte has no effect on the direction of Salesforce i.e., Salesforce and Humacyte go up and down completely randomly.
Pair Corralation between Salesforce and Humacyte
Considering the 90-day investment horizon Salesforce is expected to generate 0.46 times more return on investment than Humacyte. However, Salesforce is 2.2 times less risky than Humacyte. It trades about 0.28 of its potential returns per unit of risk. Humacyte is currently generating about -0.23 per unit of risk. If you would invest 29,137 in Salesforce on September 1, 2024 and sell it today you would earn a total of 3,862 from holding Salesforce or generate 13.25% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Salesforce vs. Humacyte
Performance |
| Timeline |
| Salesforce |
| Humacyte |
Salesforce and Humacyte Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Salesforce and Humacyte
The main advantage of trading using opposite Salesforce and Humacyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Humacyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Humacyte will offset losses from the drop in Humacyte's long position.| Salesforce vs. Ke Holdings | Salesforce vs. nCino Inc | Salesforce vs. Kingsoft Cloud Holdings | Salesforce vs. Jfrog |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |